JUVÉDERM® VOLUX™ XC FOR IMPROVEMENT OF JAWLINE DEFINITION NOW AVAILABLE NATIONWIDE

Go back to JUVÉDERM® VOLUX™ XC FOR IMPROVEMENT OF JAWLINE DEFINITION NOW AVAILABLE NATIONWIDE
AbbVie (NYSE: ABBV) Delayed: 250.33 +0.87 (0.35%)
Previous Close $249.46    52 Week High $68.12 
Open $249.49    52 Week Low $50.71 
Day High $251.49    P/E 54.30 
Day Low $248.31    EPS $4.61 
Volume 4,648,637